Early Time to Benefit with Intensive Statin Treatment: Could It Be the Pleiotropic Effects?

This publication has 30 references indexed in Scilit:

• C-Reactive Protein Levels and Outcomes after Statin Therapy
  New England Journal of Medicine, 2005
• Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology
  Current Opinion in Lipidology, 2004
• Pathological Changes in Acute Coronary Syndromes: The Role of Statin Therapy in the Modulation of Inflammation, Endothelial Function and Coagulation
  Journal of Thrombosis and Thrombolysis, 2004
• Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
  New England Journal of Medicine, 2004
• Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Effects of statins in reducing thrombotic risk and modulating plaque vulnerability
  Clinical Cardiology, 2003
• Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects
  British Journal of Clinical Pharmacology, 2002
• Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
  Life Sciences, 2000
• Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
  Circulation, 1998